Zurcher Kantonalbank Zurich Cantonalbank Has $805,000 Holdings in Moelis & Company (NYSE:MC)

Zurcher Kantonalbank Zurich Cantonalbank grew its position in Moelis & Company (NYSE:MC) by 32.8% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 14,337 shares of the asset manager’s stock after purchasing an additional 3,538 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Moelis & Company were worth $805,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Healthcare of Ontario Pension Plan Trust Fund acquired a new position in Moelis & Company in the 3rd quarter worth approximately $16,924,000. Northern Trust Corp lifted its holdings in shares of Moelis & Company by 32.7% in the third quarter. Northern Trust Corp now owns 927,705 shares of the asset manager’s stock valued at $41,867,000 after purchasing an additional 228,840 shares in the last quarter. Assenagon Asset Management S.A. acquired a new stake in shares of Moelis & Company in the third quarter worth $6,215,000. Vaughan Nelson Investment Management L.P. grew its holdings in shares of Moelis & Company by 22.1% during the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 752,615 shares of the asset manager’s stock valued at $42,244,000 after buying an additional 136,235 shares in the last quarter. Finally, Barclays PLC raised its position in Moelis & Company by 56.1% during the third quarter. Barclays PLC now owns 294,010 shares of the asset manager’s stock valued at $13,268,000 after buying an additional 105,715 shares during the period. 91.53% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Moelis & Company

In other Moelis & Company news, General Counsel Osamu R. Watanabe sold 7,685 shares of the firm’s stock in a transaction that occurred on Wednesday, February 21st. The stock was sold at an average price of $52.60, for a total value of $404,231.00. Following the sale, the general counsel now owns 6,000 shares of the company’s stock, valued at approximately $315,600. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other Moelis & Company news, General Counsel Osamu R. Watanabe sold 7,685 shares of the stock in a transaction on Wednesday, February 21st. The shares were sold at an average price of $52.60, for a total value of $404,231.00. Following the completion of the sale, the general counsel now directly owns 6,000 shares of the company’s stock, valued at approximately $315,600. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Kenneth Moelis sold 75,000 shares of the business’s stock in a transaction dated Thursday, February 29th. The stock was sold at an average price of $54.11, for a total transaction of $4,058,250.00. Following the transaction, the chief executive officer now owns 86,441 shares in the company, valued at approximately $4,677,322.51. The disclosure for this sale can be found here. Insiders sold 375,185 shares of company stock worth $20,130,225 over the last ninety days. Company insiders own 6.96% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. JMP Securities reaffirmed a “market perform” rating on shares of Moelis & Company in a research note on Tuesday, April 9th. Keefe, Bruyette & Woods reaffirmed a “market perform” rating and set a $54.00 price objective (down from $58.00) on shares of Moelis & Company in a research report on Thursday, April 25th. JPMorgan Chase & Co. increased their target price on shares of Moelis & Company from $46.00 to $57.00 and gave the stock a “neutral” rating in a research report on Thursday, February 8th. StockNews.com upgraded shares of Moelis & Company from a “sell” rating to a “hold” rating in a report on Thursday, February 8th. Finally, The Goldman Sachs Group upgraded Moelis & Company from a “sell” rating to a “neutral” rating and increased their price objective for the stock from $53.00 to $58.00 in a report on Wednesday, March 13th. Two research analysts have rated the stock with a sell rating and five have given a hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $50.80.

Moelis & Company Stock Performance

Shares of MC stock opened at $50.05 on Tuesday. The stock’s 50 day simple moving average is $53.96 and its 200 day simple moving average is $51.68. Moelis & Company has a twelve month low of $33.87 and a twelve month high of $58.67. The company has a market capitalization of $3.56 billion, a price-to-earnings ratio of -263.42 and a beta of 1.35.

Moelis & Company (NYSE:MC) last released its quarterly earnings results on Wednesday, April 24th. The asset manager reported $0.22 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.11. The company had revenue of $217.49 million for the quarter, compared to analyst estimates of $219.30 million. Moelis & Company had a negative net margin of 1.33% and a negative return on equity of 0.12%. The company’s quarterly revenue was up 17.4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.05 earnings per share. On average, analysts forecast that Moelis & Company will post 1.29 EPS for the current fiscal year.

Moelis & Company Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 20th. Shareholders of record on Monday, May 6th will be given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 4.80%. The ex-dividend date is Friday, May 3rd. Moelis & Company’s dividend payout ratio is -1,263.16%.

About Moelis & Company

Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory.